Research output per year
Research output per year
Fingerprint
Dive into the research topics where Giuseppe Cicero is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
NEPA (netupitant/palonosetron) for the antiemetic prophylaxis of nausea and vomiting induced by chemotherapy (CINV) with Folfirinox and Folfoxiri even during the COVID-19 pandemic: A real-life study
Cicero, G., Caputo, V., Ferrera, G. & Rosati, G., 2021, In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. 25, p. 5310-5317 8 p.Research output: Contribution to journal › Article › peer-review
-
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting
Cicero, G., Pizzuti, L., Barba, M., Graziano, V., Iezzi, L., Krasniqi, E., Mazzotta, M., Marinelli, D., Grassadonia, A., Amodio, A., Tinari, N., Vici, P. & Natoli, C., 2021, In: Cells. 10, p. 1685- 16 p.Research output: Contribution to journal › Article › peer-review
-
Quality of Life in Patients With Severe Skin Reactions in Course of First-Generation Epidermal Growth Factor Receptor Inhibitors Monoclonal Antibodies (Our Experience With Cetuximab)
Epifanio, M. S., Cicero, G., Fattoruso, S. I. S., Cicero, G., D’Agostino, A., Auriemma, A., Salvato, A. & Addeo, R., 2021, In: World Journal of Oncology. 12, p. 104-110 7 p.Research output: Contribution to journal › Article › peer-review
-
Tas-102 in metastatic colorectal cancer (MCRC): Efficacy, tolerability, and quality of life in heavily pretreated elderly patients: A real-life study
Gulotta, G., De Luca, R., Cicero, G., Marchesa, P., Addeo, R. & Gulotta, L., 2020, In: Drugs in Context. 9, p. 1-8 8 p.Research output: Contribution to journal › Article › peer-review
-
Use of Eribulin mesylate as second-line therapy in elderly patients with HER/2 negative metastatic breast cancer (MBC): Efficacy, tolerability and Quality of Life
Cicero, G., Genova, G., Al & Grassadonia, A., 2020, In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. 25, p. 12727-12734 8 p.Research output: Contribution to journal › Article › peer-review
Projects
- 3 Active
-
Ricerca delle cellule staminali CD133+ nel carcinoma del colon-retto e loro sensibilità ai farmaci antiblastici
Gulotta, G., D'Arpa, F., Cicero, G., Stassi, G., Salamone, G., TRAFICANTE, A., ANGILERI, M. G. & PALADINO, N. C.
1/1/06 → …
Project: Research project
-
Analisi dei polimorfismi genici e dei microRNA come fattori predittivi di risposta agli inibitori delle tirosin-chinasi (TK) e dell’ angiogenesi nel trattamento dei tumori gastrointestinali stromali (GIST)
Gebbia, N., Valerio, M. R., Fulfaro, F., Latteri, M., Vieni, S., Di Fede, G., Grassi, N., Cicero, G., Russo, A., Pantuso, G., Bazan, V., Palmeri, S. & Graceffa, G.
1/1/07 → …
Project: Research project
-
Analisi dei polimorfismi genici e della variazione del numero di copie (CNV), e identificazione di una gene e miRNA signature in pazienti affetti da tumori gastrointestinali stromali (GIST): Ruolo diagnostico, prognostico, predittivo.
Russo, A., Bruno, L., Cajozzo, M., Morello, V., Cicero, G., Gulotta, E. & Fanale, D.
1/1/12 → …
Project: Research project